Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Business: Dilip Shanghvi

Business: Dilip Shanghvi

Age: 53
Chairman and Managing Director, Sun Pharmaceuticals

Dilip Shanghvi's low-key management style has turned Sun Pharma, maker of generic and branded drugs, into one of the most profitable pharma companies in India. Sun's priorities include cardiology, neurology, and psychiatry drugs. Shanghvi pursued M&As at home and overseas at a time when Indian companies rarely went shopping. Having waged a two-year legal battle, he hopes to score a big win soon with Sun gaining control over generics drugmaker Taro Pharmaceuticals of Israel.